Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
J Clin Pathol. 2013 Sep;66(9):733-43. doi: 10.1136/jclinpath-2013-201626. Epub 2013 Apr 27.
The pathological diagnoses and classification schemes for thyroid carcinoma have changed over the past 20 years and continue to do so. New entities have been described and molecular analyses have suggested better characterisation and grouping of certain tumours. Because some of the lesions have been named differently by different authors, clinicians and patients may be confused as to what a specific patient's lesion represents. In this review, we discuss the thyroid tumours of follicular origin which are clinically unusual but important to recognise as their behaviour may be aggressive, they may not respond to radioiodine treatment and they may cause significant mortality. This paper describes these important but rare lesions, their pathological features, important clinicopathological correlations, molecular correlates and prognostic implications.
过去 20 年来,甲状腺癌的病理诊断和分类方案一直在不断变化,而且还在继续变化。新的实体已经被描述,分子分析也提示对某些肿瘤进行更好的特征描述和分组。由于某些病变在不同作者、临床医生和患者之间有不同的命名,他们可能会对特定患者的病变代表什么感到困惑。在这篇综述中,我们讨论了滤泡来源的甲状腺肿瘤,这些肿瘤在临床上不常见,但认识它们很重要,因为它们的行为可能具有侵袭性,它们可能对放射性碘治疗无反应,并且可能导致显著的死亡率。本文描述了这些重要但罕见的病变,它们的病理特征、重要的临床病理相关性、分子相关性和预后意义。